Novozymes A/S Stock

Novozymes A/S EBITDA per Employee

The EBITDA per Employee of Novozymes A/S (NSIS B.CO) as of Aug 5, 2026 is 139,268.05 EUR. In the previous year, EBITDA per Employee was 109,491.96 EUR — a change of 27.19% (higher).

EBITDA per Employee

139,268.05EUR

YoY

27.19%

Last updated:

EBITDA per Employee of Novozymes A/S is 2026 139,268.05 EUR. EBITDA per Employee of Novozymes A/S was 2025 109,491.96 EUR. It decreases by 27.19% higher compared to the previous year.
Access this data via the Eulerpool API

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novozymes A/S stock

EBITDA per Employee of Novozymes A/S is 139,268.05 EUR in 2026.

EBITDA per Employee of Novozymes A/S changed from 109,491.96 EUR to 139,268.05 EUR, representing a 27.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Novozymes A/S historically and in real time.

Access this data via the Eulerpool API

Workforce — Novozymes A/S

All Key Metrics — Novozymes A/S